Managed Care Considerations in the
Immuno-Oncology Treatment Landscape
A continuing medical education activity sponsored by NAMCP and AAMCN.
This activity is an archive from the
webinars held on October 4 and October 11, 2017.
If you participated in the live webinar, you are not eligible for
credits for this activity.
This activity is valid from November 1, 2017 to November 30, 2018
Instructions for CME/CNE: Complete the pre test, listen to the audio
and view the slides, complete the post test, complete the evaluation
form and hit submit. If you close your internet browser without
completing the post test, you will have ONE more opportunity to
complete. A score of 70% must be achieved on the post test to
receive continuing education credits. If you do not pass the post
test after two attempts, you will not be eligible to try again. Once
you complete the evaluation form and score 70% or higher on your
post test, you will automatically be given your certificate.
To print or save your certificate, you will need to click on the
“download” button and either print or save.
Audience: This activity is intended for
healthcare professionals practicing in managed care environments.
This presentation is supported by
an educational grant from
Merck Sharp & Dohme Corp
Cancer immunotherapy is the use of the immune system to treat
cancer. Immunotherapies can be categorized as active, passive or
hybrid (active and passive). These approaches exploit the fact that
cancer cells often have molecules on their surface that can be
detected by the immune system, known as tumour-associated antigens (TAAs);
they are often proteins or other macromolecules (e.g.
carbohydrates). Active immunotherapy directs the immune system to
attack tumor cells by targeting TAAs. Passive immunotherapies
enhance existing anti-tumor responses and include the use of
monoclonal antibodies, lymphocytes and cytokines. Advances in the
understanding of the immune system are changing the way the
interprofessional healthcare team manages cancer. As immunotherapies
move to the forefront of cancer treatment, healthcare professionals
will need to understand the immune system; know how cancer
circumvents it; and be aware of the mechanisms of action, efficacy,
and safety of current and emerging immunotherapies. These webinars
are designed to educate healthcare professionals on current and
emerging scientific data and to ensure that members of a
multidisciplinary team, including physicians, nurses, pharmacists
and other relevant healthcare professionals, have the knowledge and
skills necessary to apply the standards of care to their practice
and healthcare setting when managing patients with cancer who are
being treated with immunotherapies.
Upon Completion of this
activity, participants will be able to:
Analyze immuno-oncology and the
different types of immuno-oncology treatments
Identify immuno-oncology treatments
that are have been approved in the past 12 months and are likely
to be approved in the next 12 months
Discuss the impact of new immuno-oncology
treatments on the managed care market
Discuss the MoA & indications of new
and emerging immunotherapies
||Gary M. Owens, MD
Gary Owens Associates
has no real or perceived financial relationships to
disclose. His presentation has been peer reviewed for
MD has no real or perceived financial relationships to
Jeremy Williams has no real or perceived financial
relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no real or perceived
financial relationships to disclose.
NAMCP and/or the presenter
has copyright or has received permissions for use of
materials provided in this activity.
Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is
accredited by the Accreditation Council for Continuing Medical
Education to provide continuing medical education for physicians.
NAMCP designates this enduring material for a maximum of 1 AMA PRA
Category I creditsTM.
The American Association of Managed Care Nurses is accredited as a
provider of continuing nursing
education by the American Nurses Credentialing Center’s Commission
Nurses who complete this activity and achieve a passing score will
receive 1 hour in continuing
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
supported by an educational grant from
Merck Sharp & Dohme Corp
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
Click Here To Continue